Experienced in Hemolytic Anemia

Jose L. Fuster

Murcia, MU, ES 
Experienced in Hemolytic Anemia
Murcia, MU, ES 
OverviewLocationsClinical Research

Overview

Jose Fuster practices in Murcia, Spain. Mr. Fuster is rated as an Experienced expert by MediFind in the treatment of Hemolytic Anemia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Hyperferritinemia-Cataract Syndrome, Anemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Hemolytic Anemia.

Gender
Male

Locations

Murcia, MU, Spain
Other Locations
Palma, PM, Spain
El Palmar, MU, Spain
Madrid, MD 28029, Spain
Cartagena, MU, Spain

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Pilot, Prospective, Open Label, Multicenter CT, to Evaluate the Safety and Efficacy of Palbociclib (PD0332991), a Cyclin-dependent Kinase 4 and 6 (CDK4 and CDK6) Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
Phase II Pilot, Prospective, Open Label, Multicenter CT, to Evaluate the Safety and Efficacy of Palbociclib (PD0332991), a Cyclin-dependent Kinase 4 and 6 (CDK4 and CDK6) Inhibitor, in Patients With Oligodendroglioma or Recurrent Oligoastrocytoma Anaplastic With the Activity of the Protein RB Preserved
Enrollment Status: Completed
Publish Date: November 22, 2024
Intervention Type: Drug
Study Phase: Phase 2
Clinical Trial Phase IIB Randomized, Multicenter, of Continuation or Non Continuation With 6 Cycles of Temozolomide After the First 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
Clinical Trial Phase IIB Randomized, Multicenter, of Continuation or Non Continuation With 6 Cycles of Temozolomide After the First 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma.
Enrollment Status: Completed
Publish Date: January 12, 2021
Intervention Type: Drug
Study Phase: Phase 2
NK Cells Infusion as Consolidation Treatment of Acute Myeloid Leukemia in Children and Adolescents
NK Cells Infusion as Consolidation Treatment of Acute Myeloid Leukemia in Children and Adolescents
Enrollment Status: Completed
Publish Date: October 05, 2020
Intervention Type: Drug, Procedure
Study Phase: Phase 2
Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Concomitant Treatment With Cisplatin and Radiotherapy Versus Concomitant Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer.
Open Label Randomized, Multi-centre Phase III Trial of TPF Plus Concomitant Treatment With Cisplatin and Radiotherapy Versus Concomitant Cetuximab and Radiotherapy in Locally Advanced, Unresectable Head and Neck Cancer.
Enrollment Status: Completed
Publish Date: May 24, 2019
Intervention Type: Other
Study Phase: Phase 3
View 3 Less Clinical Trials

71 Total Publications

CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.
CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia.
Journal: Journal of hematology & oncology
Published: November 05, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Fuster's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile